Overexpression of runt-related transcription factor-2 Is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Li, Weiping ^a   Xu, Shujuan ^a   Lin, Shuang ^b   Zhao, Wei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Yantaishan Hosptial ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX2; RUNX2 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; AGED; CELL FRACTIONATION; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PROGNOSIS; TISSUE DISTRIBUTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84871822815     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/456534     Document Type: Article

References (29)

1. Jordan S. J., Cushing-Haugen K. L., Wicklund K. G., Doherty J. A., Rossing M. A., Breast-feeding and risk of epithelial ovarian cancer. Cancer Causes and Control 2010 21 1 109 116
2. Rota M., Pasquali E., Scotti L., Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis. Gynecologic Oncology 2012 125 3 758 763
3. Wang M., He Y., Shi L., Shi C., Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer. European Journal of Gynaecological Oncology 2011 32 2 171 177 2-s2.0-79955685973
4. Chimge N. O., Baniwal S. K., Little G. H., Regulation of breast cancer metastasis by RUNX2 and estrogen signaling: the role of SNAI2. Breast Cancer Research 2011 13, article R127
5. Slattery M. L., Lundgreen A., Herrick J. S., Caan B. J., Potter J. D., Wolff R. K., Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF- β -signaling pathway. Carcinogenesis 2011 32 3 318 326 2-s2.0-79952288107 10.1093/carcin/bgq245
6. Little G. H., Noushmehr H., Baniwal S. K., Berman B. P., Coetzee G. A., Frenkel B., Genome-wide RUNX2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Research 2012 40 3538 3547
7. Martin J. W., Zielenska M., Stein G. S., van Wijnen A. J., Squire J. A., The role of RUNX2 in osteosarcoma oncogenesis. Sarcoma 2011 2011 13 2-s2.0-79251553733 10.1155/2011/282745 282745
8. van der Deen M., Akech J., Lapointe D., Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility. The Journal of Biological Chemistry 2012 287 4503 4517
9. Chua C. W., Chiu Y. T., Yuen H. F., Chan K. W., Man K., Wang X., Ling M. T., Wong Y. C., Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform. Clinical Cancer Research 2009 15 13 4322 4335 2-s2.0-67650369580 10.1158/1078-0432.CCR-08-3157
10. Pratap J., Javed A., Languino L. R., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Molecular and Cellular Biology 2005 25 19 8581 8591 2-s2.0-25444473106 10.1128/MCB.25.19.8581-8591.2005 (Pubitemid 41369178)
11. Kayed H., Jiang X., Keleg S., Jesnowski R., Giese T., Berger M. R., Esposito I., Löhr M., Friess H., Kleeff J., Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. British Journal of Cancer 2007 97 8 1106 1115 2-s2.0-35348831090 10.1038/sj.bjc.6603984 (Pubitemid 47587005)
12. Sase T., Suzuki T., Miura K., Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor. International Journal of Cancer. In press
13. Dalle Carbonare L., Frigo A., Francia G., Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer. The Journal of Clinical Endocrinology & Metabolism 2012 97 7 E1249 E1256
14. Tandon M., Gokul K., Ali S. A., Chen Z., Lian J., Stein G. S., Pratap J., RUNX2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells. Molecular Cancer 2012 11, article 27
15. Won K. Y., Park H. R., Park Y. K., Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma. Tumori 2009 95 3 311 316 2-s2.0-67849133056
16. Onodera Y., Miki Y., Suzuki T., Takagi K., Akahira J. I., Sakyu T., Watanabe M., Inoue S., Ishida T., Ohuchi N., Sasano H., Runx2 in human breast carcinoma: its potential roles in cancer progression. Cancer Science 2010 101 12 2670 2675 2-s2.0-78449307996 10.1111/j.1349-7006.2010.01742.x
17. Blyth K., Vaillant F., Jenkins A., McDonald L., Pringle M. A., Huser C., Stein T., Neil J., Cameron E. R., Runx2 in normal tissues and cancer cells: a developing story. Blood Cells, Molecules, and Diseases 2010 45 2 117 123 2-s2.0-77955271025 10.1016/j.bcmd.2010.05.007
18. Purcell D. J., Khalid O., Ou C. Y., Recruitment of coregulator G9a by RUNX2 for selective enhancement or suppression of transcription. Journal of Cellular Biochemistry 2012 113 7 2406 2414
19. Underwood K. F., D'Souza D. R., Mochin-Peters M., Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity. Journal of Bone and Mineral Research 2012 27 913 925
20. Lee K. N., Jang W. G., Kim E. J., Orphan nuclear receptor COUP-TFII negatively regulates BMP2-induced osteoblast differentiation through suppressing RUNX2 activity. The Journal of Biological Chemistry 2012 287 23 18888 18899
21. Li Y., Ge C., Long J. P., Begun D. L., Rodriguez J. A., Goldstein S. A., Franceschi R. T., Biomechanical stimulation of osteoblast gene expression requires phosphorylation of the RUNX2 transcription factor. Journal of Bone and Mineral Research 2012 27 6 1263 1274
22. Park E. S., Lind A. K., Dahm-Kähler P., Brännström M., Carletti M. Z., Christenson L. K., Curry T. E., Jo M., RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries. Molecular Endocrinology 2010 24 4 846 858 2-s2.0-77950404648 10.1210/me.2009-0392
23. Tonomoto Y., Tachibana M., Dhar D. K., Onoda T., Hata K., Ohnuma H., Tanaka T., Nagasue N., Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis. Oncology 2007 73 5-6 346 356 2-s2.0-45549088724 10.1159/000135350 (Pubitemid 351862027)
24. Lee S. H., Che X., Jeong J. H., Runx2 protein stabilizes hypoxia-inducible factor-1 through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. The Journal of Biological Chemistry 2012 287 14760 14771
25. Edvardsson K., Ström A., Jonsson P., Gustafsson J. A., Williams C., Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells. Molecular Endocrinology 2011 25 6 969 979 2-s2.0-79957667295 10.1210/me.2010-0452
26. Nevadunsky N. S., Barbieri J. S., Kwong J., Merritt M. A., Welch W. R., Berkowitz R. S., Mok S. C., RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecologic Oncology 2009 112 2 325 330 2-s2.0-58249097238 10.1016/j.ygyno.2008.09.006
27. Jeong J. H., Choi J. Y., Interrelationship of RUNX2 and estrogen pathway in skeletal tissues. BMB Reports 2011 44 613 618
28. Duan Z. L., Peng Z. L., Wang Z. H., Expression and involved signal transduction pathway of autophagy gene Beclin 1 in epithelial ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 2007 38 2 239 242 2-s2.0-33947729658
29. Chakrabarty S., Kondratick L., Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biology and Therapy 2006 5 2 189 197 2-s2.0-33644689975 (Pubitemid 43328877)